Advances and Future Directions in Molecular Breast Imaging.
Where this comes from
- Record sourced from PubMed, PMID 34887334.
- Also identified by DOI 10.2967/jnumed.121.261988 and PMC identifier 8717200.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Molecular breast imaging (MBI) using <sup>99m</sup>Tc-sestamibi has advanced rapidly over the past decade. Technical advances allow lower-dose, higher-resolution imaging and biopsy capability. MBI can be used for supplemental breast cancer screening with mammography for women with dense breasts, as well as to assess neoadjuvant therapy response, evaluate disease extent, and predict breast cancer risk. This article highlights the current state of the art and future directions in MBI.
Medical subject headings
- Breast Neoplasms
- Molecular Imaging